Teraimmune Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$9.7M
Teraimmune General Information
Description
Developer of cell therapeutics designed to treat autoimmune diseases and immune-related disorders. The company uses regulatory Treg cells from a donor to create Treg cells for hemophilia, multiple sclerosis, and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to develop therapeutics that help suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
Contact Information
Website
www.teraimmune.comCorporate Office
- 20400 Century Boulevard
- Suite 125
- Germantown, MD 20874
- United States
Corporate Office
- 20400 Century Boulevard
- Suite 125
- Germantown, MD 20874
- United States
Teraimmune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 29-Jun-2023 | $9.7M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 22-Dec-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 15-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 2. Angel (individual) | 09-Oct-2019 | $700K | $700K | Completed | Pre-Clinical Trials | |
| 1. Grant | 01-Apr-2018 | $225K | Completed | Startup |
Teraimmune Comparisons
Industry
Financing
Details
Teraimmune Competitors (5)
One of Teraimmune’s 5 competitors is Sonoma Biotherapeutics, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sonoma Biotherapeutics | Venture Capital-Backed | San Francisco, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| GentiBio | Venture Capital-Backed | Cambridge, MA | ||||
| Quell Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| Coya Therapeutics | Formerly VC-backed | Houston, TX |
Teraimmune Patents
Teraimmune Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024520155-A | Combination composition for preventing or treating atopic dermatitis comprising functionally enhanced stem cells and regulatory t cells | Inactive | 01-Jun-2021 | ||
| CA-3225620-A1 | Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells | Pending | 01-Jun-2021 | ||
| US-20240277772-A1 | Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells | Pending | 01-Jun-2021 | ||
| WO-2022255759-A1 | Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells | Inactive | 01-Jun-2021 | ||
| AU-2022249354-A1 | Method of producing regulatory t cells by culturing regulatory t cells obtained from umbilical cord blood | Inactive | 02-Apr-2021 | C12N5/0637 |
Teraimmune Signals
Teraimmune Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alton Sports | Corporation | Minority | ||
| Arche Investment | Corporate Venture Capital | Minority | ||
| DSC Investment | Venture Capital | Minority | ||
| LogInvestment | Venture Capital | Minority | ||
| Medici Investment | Venture Capital | Minority |
Teraimmune FAQs
-
When was Teraimmune founded?
Teraimmune was founded in 2016.
-
Where is Teraimmune headquartered?
Teraimmune is headquartered in Germantown, MD.
-
What is the size of Teraimmune?
Teraimmune has 10 total employees.
-
What industry is Teraimmune in?
Teraimmune’s primary industry is Drug Discovery.
-
Is Teraimmune a private or public company?
Teraimmune is a Private company.
-
What is the current valuation of Teraimmune?
The current valuation of Teraimmune is .
-
What is Teraimmune’s current revenue?
The current revenue for Teraimmune is .
-
How much funding has Teraimmune raised over time?
Teraimmune has raised $12.9M.
-
Who are Teraimmune’s investors?
Alton Sports, Arche Investment, DSC Investment, LogInvestment, and Medici Investment are 5 of 9 investors who have invested in Teraimmune.
-
Who are Teraimmune’s competitors?
Sonoma Biotherapeutics, Sangamo Therapeutics, GentiBio, Quell Therapeutics, and Coya Therapeutics are competitors of Teraimmune.
-
When was Teraimmune acquired?
Teraimmune was acquired on 29-Jun-2023.
-
Who acquired Teraimmune?
Teraimmune was acquired by Baudax Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process